Corteva, Inc.
Corteva, Inc. (CTVA)
Overview
Corteva, Inc. is a pure-play global agriculture company that develops and sells seeds and crop-protection products to farmers around the world. Headquartered in Indianapolis, Indiana, and a member of the S&P 500 (NYSE: CTVA), Corteva was formed in 2018 as one of three companies spun out of the DowDuPont merger (the union of Dow Chemical and DuPont), becoming an independent public company in June 2019. Its lineage traces back to DuPont's legacy Pioneer Hi-Bred seed business and Dow AgroSciences' crop-protection chemistry. The company generates roughly $17-18 billion in annual revenue and employs approximately 21,500 people, selling into more than 100 countries across North America, Latin America, Europe, and Asia-Pacific.
What They Do & How They Make Money
Corteva sells the two fundamental inputs a farmer needs each growing season beyond land and labor: genetically improved seed and chemical/biological products that protect those crops from weeds, insects, and disease. On the seed side, Corteva breeds and licenses proprietary genetics and traits (for corn, soybeans, sunflowers, and other crops) under brands like Pioneer, then sells that seed — often bundled with trait technologies for herbicide tolerance or pest resistance — directly to farmers and through distribution networks, earning premium pricing for genetics that boost yield or reduce input costs. On the crop-protection side, Corteva manufactures and sells herbicides, insecticides, fungicides, nitrogen-use-efficiency products, and a growing biologicals portfolio (natural/microbial pest and plant-health products, expanded via acquisitions like Stoller Group and Symborg) to control weeds, pests, and disease and to protect yield.
Revenue is transactional and highly seasonal, tied to the Northern and Southern Hemisphere planting calendars — sales concentrate around spring planting (and to a lesser degree fall) in each hemisphere. Pricing power comes from proprietary intellectual property (patented genetics, traits, and active chemical ingredients) that differentiate Corteva's products from generic/off-patent alternatives, along with the R&D pipeline and regulatory approvals needed to keep introducing new, higher-value products (e.g., new herbicide chemistries as older ones face weed resistance, or new trait stacks). Corteva also increasingly monetizes digital agronomy tools and decision-support software that help farmers optimize input use, reinforcing product stickiness.
Business Segments
Corteva reports in two operating segments:
- Seed — Develops and supplies germplasm (the genetic base of a seed variety) and trait technologies primarily in corn, soybean, and other row-crop and specialty markets, aimed at improving yield and resistance to weather stress, disease, insects, and herbicides. This is the larger of the two segments, generating roughly $10.2 billion in trailing revenue (well over half of total company revenue), anchored by the Pioneer brand.
- Crop Protection — Supplies herbicides, insecticides, fungicides, nitrogen stabilizers, pasture/range-management herbicides, seed-applied technologies, and a growing biologicals line. This segment generates roughly $7.6 billion in trailing revenue.
In October 2025, Corteva announced plans to separate into two independent public companies — splitting the Seed business (to operate under a new brand, reported as "Vylor") from the Crop Protection business — a structural change that, once completed, will convert today's two internal segments into two standalone S&P-listed companies.
Competitors
- Seeds & Traits: Bayer (via its Monsanto/Dekalb seed and trait business), Syngenta Group (owned by China's ChemChina/Sinochem), BASF, and regional/local seed companies in each geography.
- Crop Protection: Bayer Crop Science, Syngenta, BASF Agricultural Solutions, FMC Corporation, and Chinese generic-agrochemical producers that compete on price for off-patent active ingredients.
- Broader agricultural inputs: Nutrien and Mosaic in fertilizer (an adjacent input category), and a growing set of biologicals/biotech startups competing in the sustainable-inputs niche.
Competitive Position
Corteva's competitive advantages rest on decades of accumulated germplasm libraries, a deep and expensive-to-replicate seed-breeding and trait-development pipeline, extensive patent portfolios on both genetics and crop-protection chemistry, and long-standing distribution/dealer relationships with farmers built through the Pioneer brand and other channel partners. Along with Bayer and Syngenta, Corteva is one of a small handful of companies with the global scale, regulatory expertise, and R&D budget needed to bring new seed traits and crop-protection molecules through the many years (and hundreds of millions of dollars) of development and regulatory approval required — a structural barrier that keeps the industry concentrated among a few large players ("Big Ag").
Key risks include commodity-price cyclicality — farmer profitability and input spending track crop prices (corn, soybeans, etc.), so a period of low grain prices pressures Corteva's volumes and pricing; currency exposure given its large international footprint; weather and climate volatility affecting planted acreage and yields; increasing pest/weed resistance that can erode the effectiveness (and value) of existing chemistries, requiring continuous R&D reinvestment; and regulatory/political risk around pesticide approvals and restrictions (e.g., scrutiny of certain herbicides and neonicotinoid insecticides in various jurisdictions). The pending separation into two independent companies is itself a near-term source of execution risk and uncertainty — it will change Corteva's scale, cost structure, and capital allocation, and investors are still assessing how each resulting entity will compete on a standalone basis.